RYTM
Rhythm Pharmaceuticals, Inc. · NASDAQ
- Sector Health Technology
- Industry Biotechnology
- Website rhythmtx.com
- Employees(FY) 177
- ISIN US76243J1051
Performance
-1.4%
1W
-1.45%
1M
-22.89%
3M
+16.94%
6M
-17.42%
YTD
+130.48%
1Y
Profile
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a rare melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convertase subtilisin/kexin type 1, leptin receptor (LEPR) deficiency obesity, and Bardet-Biedl and Alström syndrome. It is also developing setmelanotide, which is in Phase 3 clinical trials for treating POMC or LEPR heterozygous deficiency obesities, steroid receptor coactivator 1 deficiency obesity, SH2B1 deficiency obesity, MC4 receptor deficiency obesity, and other MC4R disorders. The company was formerly known as Rhythm Metabolic, Inc. and changed its name to Rhythm Pharmaceuticals, Inc. in October 2015. Rhythm Pharmaceuticals, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.
Investment Analysis Report: RYTM
Overview
In this investment analysis report, we will delve into the financial statements of RYTM, a company in the Health Technology sector specializing in Biotechnology. We will analyze the Balance Sheets, Income Statements, and Cashflow Statements to gain insights into the company's financial health, growth pro...
Technical Analysis of RYTM 2024-05-10
Overview:
In analyzing the technical indicators for RYTM over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement. By examining these key aspects, we aim to offer valuable insights and predictions for the upcoming days.
Trend Indicators...
Recent News & Updates
- 2024-05-09 16:01
- 2024-05-09 04:01
- 2024-05-08 10:51
- 2024-05-08 03:06
- 2024-05-07 22:34
Q1 2024 Rhythm Pharmaceuticals Inc Earnings Call(Thomson Reuters StreetEvents)
- 2024-05-07 14:52
The 3 Best Nasdaq Stocks to Buy in May 2024(InvestorPlace)
- 2024-05-07 08:36
- 2024-05-07 08:15
- 2024-05-07 07:00
- 2024-05-07 02:52
The 3 Best Nasdaq Stocks to Buy in May 2024(Investorplace)
- 2024-05-06 20:58
- 2024-05-06 20:15
- 2024-05-06 19:00
- 2024-05-06 08:00
- 2024-05-05 20:00
- 2024-05-01 10:01
- 2024-04-30 10:01
- 2024-04-29 22:01
- 2024-04-29 18:30
- 2024-04-29 06:30
- 2024-04-27 21:20
Jim Cramer Portfolio: 11 Latest Stocks to Buy(Insidermonkey)
- 2024-04-24 16:01
- 2024-04-24 04:01
- 2024-04-16 16:01
- 2024-04-16 04:01
- 2024-04-14 08:46
- 2024-04-10 06:40
- 2024-04-01 08:00
- 2024-03-31 20:00
- 2024-03-25 08:00
Page 1 of 6
previousnext